Medicenna Therapeutics Corp. (MDNAF) stock
MDNAFOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2023, year ended Mar 31, 2023Last filing: 20-F on Jun 27, 2023
$0.28−0.02 (-7.63%)
Close on Oct 19, 2026
Medicenna Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Medicenna Therapeutics's operating cash flow for the twelve months ending Mar 31, 2022 was -C$23.58M. For fiscal 2022 it was -C$23.58M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Mar 31, 2022 | -C$23.58M | – |
| FY2021 | Mar 31, 2021 | -C$15.31M | – |
| FY2020 | Mar 31, 2020 | -C$5.42M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -C$12.66M | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -C$23.58M | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -C$15.31M | – |
See a number that looks wrong?